Senior Business Systems Analyst at Alector

South San Francisco, California, United States

Alector Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Proven ability working on validated applications in a pharmaceutical or regulated environment, and Veeva experience. Veeva Vault certification required
  • Experience and knowledge of the quality, clinical and regulatory business processes
  • Direct hands-on experience implementing GxP computerized systems and maintaining systems in a validated state
  • Strong process improvement skills
  • Strong database experience. Snowflake experience and certification are desirable
  • Strong reporting and analytical skills using technologies like Power BI, Tableau, Spotfire etc
  • Master Data Management experience is desirable
  • Must have demonstrated business and technology skills with success in providing technology solutions
  • System Administration experience with the Veeva Vault Platform and Vault Safety
  • Experience with FDA E2B (R3) Safety Gateway, Signal Detection and Medical Information/Safety integration
  • Experience with other regulated applications, such as ComplianceWire Learning Management Systems, Statistical Computing (SAS) and other Veeva Vault systems
  • Database and Computer Networking Knowledge
  • Experience in maintenance and support of SaaS Systems
  • Experience with Reporting and Analytics platforms and tools

Responsibilities

  • Provide Operational Support (includes management of system access and permissions and monitor health of GxP systems)
  • Perform change management activities per established Change management procedures
  • Engage with users and the Veeva technical team to analyze and resolve issues
  • Maintain Systems and systems Operations/Administration documentation
  • Analyze user enhancement requests to deliver solutions focused on establishing and improving business processes that improve efficiency, address process gaps, and enable automation and growth of the organization
  • Taking ownership of new system implementations and systems enhancements projects
  • Taking ownership of GxP Systems support
  • Taking ownership of data compilation tasks (eg. Medical Affairs data extracts)
  • Taking ownership of Systems Change processes

Skills

Veeva Vault Platform
Vault Safety
FDA E2B R3
Safety Gateway
Signal Detection
ComplianceWire
GxP Systems
Change Management
System Administration

Alector

Develops therapies for neurodegenerative diseases

About Alector

Alector develops therapies aimed at treating neurodegenerative diseases like Alzheimer's and Parkinson's. The company focuses on research and development of new drug candidates by utilizing knowledge from immunology, neurology, and human genetics. Their approach involves conducting early-stage clinical trials to gather specific data about diseases, which helps improve the chances of success for their treatments. Alector differentiates itself from competitors by emphasizing the body's natural healing processes in their drug development. The company's goal is to create effective treatments for conditions that currently have limited options, while also attracting funding and partnerships through their research findings.

San Francisco, CaliforniaHeadquarters
2013Year Founded
$189.2MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Flexible Work Hours
Hybrid Work Options

Risks

Failure in AL002 trial may decrease investor confidence and financial stability.
Reliance on external financing increases financial risk if therapies don't succeed commercially.
Increased competition in neurodegenerative market could impact Alector's market share.

Differentiation

Alector combines antibody technology with neuroimmunology for novel neurodegenerative therapies.
Strategic alliance with Adimab enhances Alector's antibody discovery and optimization capabilities.
Focus on genetically validated therapies aligns with personalized medicine trends.

Upsides

Increased interest in neuroimmunology boosts investment and collaboration opportunities for Alector.
AI-driven drug discovery enhances efficiency, aligning with Alector's technology-driven strategy.
Expansion of strategic alliances offers collaboration and resource sharing opportunities for Alector.

Land your dream remote job 3x faster with AI